AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie scope 1 Fugitive GHG Emissions (tCO2e)
AbbVie ESG Action Reports
Latest, FY2025
3,873.00
Period ended Dec 31, 2025
Change on a year earlier
+62.3%
2,387.00 in FY2024
History
5 years
Since FY2021
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scope 1 Fugitive GHG Emissions (tCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,873.00 | +62.3% | AbbVie 2025 ESG Action Report ↗ |
| FY2024 | Dec 31, 2024 | 2,387.00 | -50.7% | AbbVie 2025 ESG Action Report ↗ |
| FY2023 | Dec 31, 2023 | 4,840.00 | -9.0% | AbbVie 2025 ESG Action Report ↗ |
| FY2022 | Dec 31, 2022 | 5,319.00 | -3.3% | AbbVie 2023 ESG Action Report ↗ |
| FY2021 | Dec 31, 2021 | 5,501.00 | – | AbbVie 2023 ESG Action Report ↗ |
Cite this data
StockData. (2026). AbbVie Scope 1 Fugitive GHG Emissions (tCO2e), annual FY2021–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/esg_scope1_fug
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.